EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC 4.0

High‐dose folic acid and cancer risk; unjustified concerns by von Wrede and colleagues regarding our paper

Marte-Helene Bjørk iD, Torbjörn Tomson iD, Julie Werenberg Dreier iD, Silje Alvestad iD, Nils Erik Gilhus iD, Mika Gissler iD, Jannicke Igland iD, Maarit K Leinonen iD, Yuelian Sun iD, Håkon Magne Vegrim iD, Helga Zoega iD, Jakob Christensen iD

Epilepsia · 2023

DOI: 10.1111/epi.17717 ↗

Kurz gefasst

Kommentar in der Zeitschrift Epilepsia, 2023. Verfasst von Marte-Helene Bjørk und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Folic Acid, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NordForsk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Women using antiseizure medication in pregnancy are often advised to use high doses of folic acid supplements (1mg to 5 mg) to reduce the risk of teratogenicity. Recently, we published a report showing an association between maternal prescription fill of high dose folic acid in relation to pregnancy and childhood cancer in the offspring. The report has sparked a debate about which dose of folic acid that should be recommended in pregnancy in women in need of antiseizure medication. In this Commentary, we explain our findings and the method used in our report, and answer recent questions that have emerged.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidNeoplasmsPregnancyFemaleHumansChildDietary SupplementsRiskFamily

Stichwörter der Autor:innen

B vitaminsanticonvulsant drugsantiepileptic drugchildhood cancerepilepsyfolatepregnancy

Substanzen

Folic Acid

Autor:innen und Institutionen

  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • National Centre for Register-Based Research, School of Business and Social Sciences, Aarhus University, Aarhus, Denmark.
  • National Centre for Epilepsy, Oslo University Hospital, Oslo, Norway.
  • Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland.

ORCID-Profile: Marte-Helene Bjørk, Torbjörn Tomson, Julie Werenberg Dreier, Silje Alvestad, Nils Erik Gilhus, Mika Gissler, Jannicke Igland, Maarit K Leinonen, Yuelian Sun, Håkon Magne Vegrim, Helga Zoega, Jakob Christensen

Förderung

  • NordForsk

Zitieren

APA

Bjørk, M. H., Tomson, T., Dreier, J. W., Alvestad, S., Gilhus, N. E., Gissler, M., Igland, J., Leinonen, M. K., Sun, Y., Vegrim, H. M., Zoega, H., & Christensen, J. (2023). High‐dose folic acid and cancer risk; unjustified concerns by von Wrede and colleagues regarding our paper. Epilepsia. https://doi.org/10.1111/epi.17717

Vancouver

Bjørk MH, Tomson T, Dreier JW, Alvestad S, Gilhus NE, Gissler M, et al. High‐dose folic acid and cancer risk; unjustified concerns by von Wrede and colleagues regarding our paper. Epilepsia. 2023. doi:10.1111/epi.17717

BibTeX
@article{Bjrk2023,
  author = {Bjørk, Marte-Helene and Tomson, Torbjörn and Dreier, Julie Werenberg and Alvestad, Silje and Gilhus, Nils Erik and Gissler, Mika and Igland, Jannicke and Leinonen, Maarit K and Sun, Yuelian and Vegrim, Håkon Magne and Zoega, Helga and Christensen, Jakob},
  title = {High‐dose folic acid and cancer risk; unjustified concerns by von Wrede and colleagues regarding our paper},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17717}
}
Kostenlos starten →